表紙
市場調查報告書
商品編碼
1069641

老化細胞消除藥的全球市場:各類型,各用途,各流通管道,各地區,競爭預測及機會,2017年∼2027年

Global Senolytic Drugs Market, By Type, By Application, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2017-2027

出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

全球老化細胞消除藥的市場規模,在預測期間內預計顯著成長。

該市場的成長,起因於抗老化治療藥和醫藥品的需求高漲。醫藥品的進步和對健康壽命的需求高漲,加速全球老化細胞消除藥市場成長。

本報告提供全球老化細胞消除藥市場相關調查,市場概要,以及各類型,各用途,各流通管道,各地區的趨勢,競爭趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 COVID-19對全球老化細胞消除藥市場的影響

第5章 客戶的迴響

第6章 臨床試驗

  • 進行中的臨床試驗
  • 完成的臨床試驗
  • 中斷的臨床試驗
  • 臨床試驗分析

第7章 專利分析

第8章 全球老化細胞消除藥市場預測

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型(FOXO4相關肽,bcl-2家族抑制劑,Src蛋白酪氨酸激酶抑制劑,Navitoclax,Dasatinib及槲皮素,其他)
    • 各用途(長壽,老化抑制,心血管疾病,神經退化性疾病,其他)
    • 各流通管道(零售藥局,醫院藥局,線上藥局)
    • 各企業(2021年)
    • 各地區
  • 產品市場地圖

第9章 北美的老化細胞消除藥市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 北美:各國分析

第10章 歐洲的老化細胞消除藥市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 歐洲:各國分析

第11章 亞太地區的老化細胞消除藥市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 亞太地區:各國分析

第12章 南美的老化細胞消除藥市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 南美:各國分析

第13章 中東、非洲的老化細胞消除藥市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 中東、非洲:各國分析

第14章 市場動態

  • 促進因素
  • 課題

第15章 市場趨勢與發展

第16章 競爭情形

  • AgeX Therapeutics, Inc.
  • Cleara Biotech
  • Eternans Ltd.
  • FoxBio Inc
  • Numeric Biotech
  • T.A. Sciences, Inc.
  • Recursion Pharmaceuticals, Inc.

第17章 策略性推薦事項

目錄
Product Code: 8205

The global senolytic drugs market is expected to grow at a significant rate during the forecast period. The market growth can be attributed to the rising demands for anti-aging therapeutics and pharmaceuticals. Advances in pharmaceutical drugs and the increasing need for healthy lifespan are accelerating the growth of the global senolytic drugs market. Senescence is a condition or process where cell ages and permanently stop dividing but does not die. In some time, these cells can start accumulating and form a tumor or the development of cancer. The biological process can also result in weaker eyesight, skin wrinkling, lesser hearing capacity, etc. Senolytic drugs are designed to target the senescent cells and destroy them with their effects. Increasing demand for anti-aging drugs and pharmaceutical products to increase the lifespan of human beings are expected to drive the growth of the senolytic drugs market. According to the U.N. Economic and Social Affairs statistics, the number of people aged 65 years and above is expected to grow by 120% and reach around 1.5 billion by 2050. Thus, the increasing geriatric population across the globe is anticipated to propel the growth of the global senolytic drugs market. Moreover, the rising incidences of age-related disorders like cataracts, glaucoma, neurodegenerative diseases, cardiovascular diseases, pulmonary infections, etc., and sedentary lifestyle among the global population are driving the growth of the global senolytic drugs market. The emergence of advanced technologies, from gene therapy to stem cells, and ongoing research activities for innovation in pharmaceutical drugs are anticipated to fuel the growth of the global senolytic drugs market. Accelerating demand for improving and optimizing personalized and preventive care is further driving the growth of the global senolytic drugs market.

The global senolytic drugs market segmentation is based on type, application, distribution channel, regional distribution, and competitive landscape. Based on application, the global senolytic drugs market is divided into longevity, senescence inhibition, cardiovascular diseases, neural degenerative diseases, and others. The longevity segment is expected to dominate the market in the coming years because of the rapidly increasing geriatric population and rising demand for pharmaceutical products aiding the healthy lifespan of humans.

Major players operating in the global senolytic drugs market are AgeX Therapeutics, Inc., Cleara Biotech, Eternans Ltd., FoxBio Inc., Numeric Biotech, T.A. Sciences, Inc., Recursion Pharmaceuticals, Inc, etc.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022E

Forecast Period: 2023F-2027F

Objective of the Study:

  • To analyze the historical growth in the market size of global senolytic drugs market from 2017 to 2021.
  • To estimate and forecast the market size of global senolytic drugs market from 2022E to 2027F and growth rate until 2027F.
  • To classify and forecast global senolytic drugs market based on type, application, distribution channel, region, and competitive landscape.
  • To identify dominant region or segment in the global senolytic drugs market.
  • To identify drivers and challenges for global senolytic drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global senolytic drugs market.
  • To identify and analyze the profile of leading players operating in global senolytic drugs market.
  • To identify key sustainable strategies adopted by market players in global senolytic drugs market.

Report Scope:

In this report, global senolytic drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Senolytic Drugs Market, By Type:

FOXO4-related peptides

bcl-2 Family Inhibitors

Src Tyrosine Kinase Inhibitors

Navitoclax

Dasatinib & Quercetin

Others

  • Senolytic Drugs Market, By Application:

Longevity

Senescence Inhibition

Cardiovascular Diseases

Neural Degenerative Diseases

Others

  • Senolytic Drugs Market, By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

  • Senolytic Drugs Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research was not able to include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global senolytic drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Senolytic drugs manufacturing companies/partners
  • Suppliers/Distributers
  • End-Users
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to global senolytic drugs market

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc. besides allowing them in strategizing investments and capitalizing on market opportunities.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global senolytic drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Senolytic Drugs Market

5. Voice of Customer

  • 5.1. Preference, By Type
  • 5.2. Factors Contributing to Demand for Senolytic Drugs
  • 5.3. Barriers to Adoption of Senolytic Drugs
  • 5.4. Brand Awareness

6. Clinical Trials

  • 6.1. Ongoing Clinical Trials
  • 6.2. Completed Clinical Trials
  • 6.3. Terminated Clinical Trials
  • 6.4. Clinical Trial Analysis

7. Patent Analysis

  • 7.1. Patent Granted (2016-2020)
  • 7.2. Patent Applications Filed

8. Global Senolytic Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, Others)
    • 8.2.2. By Application (Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative Diseases, Others)
    • 8.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
    • 8.2.4. By Company (2021)
    • 8.2.5. By Region
  • 8.3. Product Market Map

9. North America Senolytic Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Senolytic Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Mexico Senolytic Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Canada Senolytic Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Distribution Channel

10. Europe Senolytic Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. Europe: Country Analysis
    • 10.3.1. France Senolytic Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Germany Senolytic Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. United Kingdom Senolytic Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Distribution Channel
    • 10.3.4. Italy Senolytic Drugs Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By Application
        • 10.3.4.2.3. By Distribution Channel
    • 10.3.5. Spain Senolytic Drugs Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Type
        • 10.3.5.2.2. By Application
        • 10.3.5.2.3. By Distribution Channel

11. Asia-Pacific Senolytic Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Application
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country
  • 11.3. Asia-Pacific: Country Analysis
    • 11.3.1. China Senolytic Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By Distribution Channel
    • 11.3.2. India Senolytic Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By Distribution Channel
    • 11.3.3. South Korea Senolytic Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By Distribution Channel
    • 11.3.4. Japan Senolytic Drugs Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Type
        • 11.3.4.2.2. By Application
        • 11.3.4.2.3. By Distribution Channel
    • 11.3.5. Australia Senolytic Drugs Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Type
        • 11.3.5.2.2. By Application
        • 11.3.5.2.3. By Distribution Channel

12. South America Senolytic Drugs Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Type
    • 12.2.2. By Application
    • 12.2.3. By Distribution Channel
    • 12.2.4. By Country
  • 12.3. South America: Country Analysis
    • 12.3.1. Brazil Senolytic Drugs Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Type
        • 12.3.1.2.2. By Application
        • 12.3.1.2.3. By Distribution Channel
    • 12.3.2. Argentina Senolytic Drugs Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Type
        • 12.3.2.2.2. By Application
        • 12.3.2.2.3. By Distribution Channel
    • 12.3.3. Colombia Senolytic Drugs Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Type
        • 12.3.3.2.2. By Application
        • 12.3.3.2.3. By Distribution Channel

13. Middle East and Africa Senolytic Drugs Market Outlook

  • 13.1. Market Size & Forecast
    • 13.1.1. By Value
  • 13.2. Market Share & Forecast
    • 13.2.1. By Type
    • 13.2.2. By Application
    • 13.2.3. By Distribution Channel
    • 13.2.4. By Country
  • 13.3. MEA: Country Analysis
    • 13.3.1. South Africa Senolytic Drugs Market Outlook
      • 13.3.1.1. Market Size & Forecast
        • 13.3.1.1.1. By Value
      • 13.3.1.2. Market Share & Forecast
        • 13.3.1.2.1. By Type
        • 13.3.1.2.2. By Application
        • 13.3.1.2.3. By Distribution Channel
    • 13.3.2. Saudi Arabia Senolytic Drugs Market Outlook
      • 13.3.2.1. Market Size & Forecast
        • 13.3.2.1.1. By Value
      • 13.3.2.2. Market Share & Forecast
        • 13.3.2.2.1. By Type
        • 13.3.2.2.2. By Application
        • 13.3.2.2.3. By Distribution Channel
    • 13.3.3. UAE Senolytic Drugs Market Outlook
      • 13.3.3.1. Market Size & Forecast
        • 13.3.3.1.1. By Value
      • 13.3.3.2. Market Share & Forecast
        • 13.3.3.2.1. By Type
        • 13.3.3.2.2. By Application
        • 13.3.3.2.3. By Distribution Channel

14. Market Dynamics

  • 14.1. Drivers
  • 14.2. Challenges

15. Market Trends & Developments

16. Competitive Landscape

  • 16.1. AgeX Therapeutics, Inc.
  • 16.2. Cleara Biotech
  • 16.3. Eternans Ltd.
  • 16.4. FoxBio Inc
  • 16.5. Numeric Biotech
  • 16.6. T.A. Sciences, Inc.
  • 16.7. Recursion Pharmaceuticals, Inc.

17. Strategic Recommendations